 2012 ONS Congress Abstract Submission deadline Jan 10th (11/9/11)
Abstract submissions for the 2012 ONS Congress in New Orleans, LA are being accepted electronically through January 10, 2012. Visit http://ons-congress2012.abstractcentral.com/ to upload your abstract. Instructions for abstract submissions is available via this site as well. Apply for an ONS Congress Scholarship to off-set travel costs (9/22/11)
ONS is now accepting scholarship appplications for the 2012 Congress meeting. Awards up to $1,200 are available. Visit http://www.onsfoundation.org/apply/ed/Congress for more information. Fundamentals of Blood & Marrow Transplant Webcourse - 2011 dates posted (12/21/10)
The new ONS educational course "Fundamentals of Blood and Marrow Transplant Webcourse" will have 6 sessions during 2011. The Webcourse is an 8 week, comprehensive, self-paced, web-based course on the fundamentals of BMT and includes 19 hours of CEU's to those that complete the course and post course exam.
Visit http://www.ons.org/CourseDetail.aspx?course_id=86 for more details.
Thank you to all the BMT SIG members who made this course a reality. Next step, BMT specialty certification!
First patient treated in stem cell study: new release of interest (10/14/10)
The first patient has been treated with human embryonic stem cells in the first study authorized by the Food and Drug Administration to test the controversial therapy.
A patient who was partially paralyzed by a spinal cord injury had millions of embryonic stem cells injected into the site of the damage, according to an announcement early Monday by the Geron Corp. of Menlo Park, Calif., which is sponsoring the groundbreaking study.
The patient was treated at the Shepherd Center, a 132-bed hospital in Atlanta that specializes in spinal cord and brain injuries, Geron said. The hospital is one of seven sites participating in the study, which is primarily aimed at testing whether the therapy is safe. Doctors will, however, also conduct a series of specially designed tests to see whether the treatment helps the patients. No additional information about the first patient was released.
Here's a link to the announcement.
The study marks a milestone in stem cell research, which is considered one of the most promising developments in medical research in decades but has been fraught with controversy. Here's a recent story about the study.
The announcement comes as the future of federal funding for embryonic stem cell research remains in doubt. A federal judge ruled in August that the Obama administration's more permissive policy for funding the research violated a federal law prohibiting taxpayer money being used for research that involves the destruction of human embryos. The Justice Department is appealing.
For more information, visit the weblink below.
http://www.geron.com/investors/factsheet/pressview.aspx?id=1235 HSCT practice variation article (5/27/10)
HSCT Practice Variation Study supported by the ONS BMT SIG is available online at http://ons.metapress.com/content/03g642h753568307/fulltext.html. A PDF copy is avaialble via the 'associate file' below. Who is your BMSCT SIG regional reporter? (3/10/07)
Check the BMSCT SIG web site for updates on your regional reporter! This is your link to the BMSCT SIG's link to BMT nurses across the country AND your link to the SIG!
Click here to receive BMTSCT SIG announcements by email!
 |